Electrolyte disorders and substitution fluid in continuous renal replacement therapy

Area of Science:

• Nephrology
• Critical Care Medicine
• Biochemistry

Background:

• Acute renal failure (ARF) management often involves continuous convective techniques like continuous arteriovenous hemofiltration (CAVH).
• Electrolyte homeostasis is critical in critically ill patients undergoing renal replacement therapy.
• Fluid and electrolyte derangements can occur rapidly without vigilant monitoring during continuous renal replacement therapy (CRRT).

Purpose of the Study:

• To analyze electrolyte balances during ARF treated with continuous convective techniques.
• To provide guidance on optimizing replacement fluid composition for CRRT.
• To highlight potential electrolyte complications and monitoring needs.

Main Methods:

• Analysis of electrolyte concentrations in plasma and ultrafiltrate during CAVH and continuous hemodialysis.
• Evaluation of the impact of replacement and dialysate fluid composition on electrolyte levels.
• Review of electrolyte management strategies in CRRT.

Main Results:

• Plasma sodium concentration is a key determinant of ultrafilterable sodium.
• Replacement fluids must include calcium, magnesium, and potassium to prevent deficiencies during CAVH.
• Dialysate composition significantly influences sodium and calcium removal in continuous hemodialysis, while magnesium and potassium can be adjusted to prevent hypokalemia and hypomagnesemia.
• Dialysis-induced hypophosphatemia is a risk requiring monitoring and supplementation.

Conclusions:

• Optimal electrolyte management during CRRT depends on precise prescription and continuous monitoring of fluid and electrolyte balance.
• Careful adjustment of replacement and dialysate solutions is essential to prevent hypocalcemia, hypomagnesemia, hypokalemia, and hypophosphatemia.
• Vigilant monitoring is paramount to avoid serious derangements in critically ill patients undergoing CRRT.